| Home |  | Fractures |
Product description:
Synjectos®
is a synthetic, sterile osteoconductive material for filling of bone defects.
The material consists of a powder source consisting of calcium and phosphate
salts and a liquid component, consisting of an aqueous phosphate solution.
After combining the powder and the liquid by thorough mixing a paste is formed
which is hardening into an apatitic structure resembling the inorganic
structure of natural bone. No materials of biological origin are used during
the manufacturing of Synjectos®
Synjectos® is to be used in all bone
defects stabilized by an appropriate surgical procedure at the fracture site,
e.g. humeral head fractures, distal radius fractures, tibia head impression
fractures, calcaneal fractures, filling of benign bone cysts or filling of bony
defects after bone harvesting for autologous bone graft and filling of bone
cavities of collapsed VB fractures such as wedge fractures (A1.1 and A1.2, A3.1
after additional surgical stabilization) after fracture reduction procedures.
Attension:
Synjectos® should be used exclusively by surgeons who are familiar with the handling of calcium phosphate cements and the corresponding surgical techniques like treatment of osseous defects.
Contract-indications:
Synjectos® must NOT BE implanted in following circumstances:
-Acute or chronic infections on the implantation site.
-Presence of malign tumors.
-Presence of osseous infections and inflammations like osteomyelitis.
-Defects in direct apposition of open epiphyseal areas.
-Renal or severe hepatic dysfunction.
-Treatment with immunosupressive drugs.
Synjectos® must NOT BE implanted in following circumstances:
-Acute or chronic infections on the implantation site.
-Presence of malign tumors.
-Presence of osseous infections and inflammations like osteomyelitis.
-Defects in direct apposition of open epiphyseal areas.
-Renal or severe hepatic dysfunction.
-Treatment with immunosupressive drugs.